{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:51:48Z","timestamp":1791705108500,"version":"4.3.4"},"reference-count":142,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jem-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Emergency Medicine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jemermed.2023.12.003","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T20:05:16Z","timestamp":1702670716000},"page":"e441-e456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multiple Sclerosis: An Emergency Medicine-Focused Narrative Review"],"prefix":"10.1016","volume":"66","author":[{"given":"Jessica","family":"Pelletier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davis","family":"Sugar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Koyfman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4770-8869","authenticated-orcid":false,"given":"Brit","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jemermed.2023.12.003_bib0001","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.1689076","article-title":"T cells responsive to myelin basic protein in patients with multiple sclerosis","volume":"247","author":"Allegretta","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0002","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1084\/jem.179.3.973","article-title":"Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis","volume":"179","author":"Zhang","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.jemermed.2023.12.003_sbref0003","series-title":"Atlas of MS 3rd edn. PART 1: Mapping Multiple Sclerosis around the World: Key Epidemiology Findings","year":"2020"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102816","article-title":"Clinical features of late-onset multiple sclerosis: a systematic review and meta-analysis","volume":"50","author":"Naseri","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ncl.2010.12.010","article-title":"Epidemiology of multiple sclerosis","volume":"29","author":"Ramagopalan","year":"2011","journal-title":"Neurol Clin"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0006","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Multiple sclerosis","volume":"343","author":"Noseworthy","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0007","series-title":"HLA-DRB1 major histocompatibility complex, class II, DR beta 1 [Homo sapiens (human)]","year":"2023"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0008","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(08)70042-5","article-title":"Environmental factors and multiple sclerosis","volume":"7","author":"Ebers","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0009","first-page":"797","article-title":"Gender issues in multiple sclerosis: an update","volume":"6","author":"Jobin","year":"2010","journal-title":"Womens Health"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0010","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S1474-4422(10)70086-7","article-title":"Vitamin D and multiple sclerosis","volume":"9","author":"Ascherio","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0011","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/aje\/154.1.69","article-title":"Cigarette smoking and incidence of multiple sclerosis","volume":"154","author":"Hernan","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0012","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1177\/1352458511403794","article-title":"High nationwide prevalence of multiple sclerosis in Sweden","volume":"17","author":"Ahlgren","year":"2011","journal-title":"Mult Scler J"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0013","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1093\/brain\/aws099","article-title":"The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service","volume":"135","author":"Wallin","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0014","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/jnnp.2008.162784","article-title":"Effect of immigration on multiple sclerosis sex ratio in Canada: the Canadian Collaborative Study","volume":"81","author":"Orton","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0015","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.annepidem.2011.03.001","article-title":"Smoking and increased risk of multiple sclerosis: parallel trends in the sex ratio reinforce the evidence","volume":"21","author":"Palacios","year":"2011","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0016","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","article-title":"Epstein\u2013Barr virus and multiple sclerosis","volume":"21","author":"Soldan","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0017","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1212\/01.WNL.0000101723.79681.38","article-title":"Vitamin D intake and incidence of multiple sclerosis","volume":"62","author":"Munger","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0018","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jamaneurol.2015.2742","article-title":"Association of vitamin D levels with multiple sclerosis activity and progression in patients receiving interferon beta-1b","volume":"72","author":"Fitzgerald","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0019","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1055\/s-0038-1649502","article-title":"Multiple sclerosis","volume":"38","author":"Yamout","year":"2018","journal-title":"Semin Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0020","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.pjnns.2015.07.006","article-title":"Evolution of diagnostic criteria for multiple sclerosis","volume":"49","author":"Przybek","year":"2015","journal-title":"Neurol Neurochir Pol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0021","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0022","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1474-4422(05)70071-5","article-title":"Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis","volume":"4","author":"Miller","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0023","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.msard.2013.11.004","article-title":"Emergency department visits before the diagnosis of MS","volume":"3","author":"Farber","year":"2014","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0024","first-page":"247","article-title":"Optimizing therapeutics in the management of patients with multiple sclerosis: a review of drug efficacy, dosing, and mechanisms of action","volume":"7","author":"Damal","year":"2013","journal-title":"Biologics"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0025","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/B978-0-444-64076-5.00046-6","article-title":"Multiple sclerosis","volume":"148","author":"Cotsapas","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0026","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1212\/01.wnl.0000335764.14513.1a","article-title":"Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome","volume":"72","author":"Okuda","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0027","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/archopht.121.7.944","article-title":"High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial","volume":"121","author":"Beck","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0028","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMoa011341","article-title":"A longitudinal study of abnormalities on MRI and disability from multiple sclerosis","volume":"346","author":"Brex","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0029","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1212\/01.WNL.0000082654.99838.EF","article-title":"The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"61","author":"Frohman","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archneur.61.2.217","article-title":"Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis","volume":"61","author":"Minneboo","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0031","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1191\/1352458505ms1194oa","article-title":"Acute partial transverse myelitis with normal cerebral magnetic resonance imaging: transition rate to clinically definite multiple sclerosis","volume":"11","author":"Scott","year":"2005","journal-title":"Mult Scler J"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0032","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3389\/fimmu.2018.01097","article-title":"Relapsing\u2013remitting multiple sclerosis is characterized by a T follicular cell pro-inflammatory shift, reverted by dimethyl fumarate treatment","volume":"9","author":"Cunill","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0033","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jamaneurol.2020.4689","article-title":"Diagnosis of progressive multiple sclerosis from the imaging perspective: a review","volume":"78","author":"Filippi","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0034","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00062-022-01144-3","article-title":"Magnetic resonance imaging in primary progressive multiple sclerosis patients: review","volume":"32","author":"Siger","year":"2022","journal-title":"Clin Neuroradiol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0035","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0036","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ana.24564","article-title":"Primary progressive multiple sclerosis evolving from radiologically isolated syndrome: preprogressive phase of PPMS","volume":"79","author":"Kantarci","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0037","doi-asserted-by":"crossref","first-page":"e90509","DOI":"10.1371\/journal.pone.0090509","article-title":"Radiologically isolated syndrome: 5-year risk for an initial clinical event","volume":"9","author":"Okuda","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0038","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00415-009-5063-0","article-title":"Clinical predictors of early second event in patients with clinically isolated syndrome","volume":"256","author":"Mowry","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0039","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1212\/01.wnl.0000234031.30756.a0","article-title":"Are initial demyelinating event recovery and time to second event under differential control?","volume":"67","author":"West","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0040","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1001\/archneur.57.7.974","article-title":"Multiple sclerosis\u2014from probable to definite diagnosis: a 7-year prospective study","volume":"57","author":"Achiron","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0041","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(00)04725-5","article-title":"Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study","volume":"357","author":"Comi","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0042","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ana.21886","article-title":"Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis","volume":"67","author":"L\u00fcnemann","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0043","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1177\/1352458508093679","article-title":"Smoking is a risk factor for early conversion to clinically definite multiple sclerosis","volume":"14","author":"Di Pauli","year":"2008","journal-title":"Mult Scler J"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0044","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/brain\/awm329","article-title":"Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis","volume":"131","author":"Fisniku","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/WNL.0b013e31827b1a67","article-title":"Spinal cord lesions in patients with clinically isolated syndrome: a powerful tool in diagnosis and prognosis","volume":"80","author":"Sombekke","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0046","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1093\/brain\/awv105","article-title":"Defining high, medium and low impact prognostic factors for developing multiple sclerosis","volume":"138","author":"Tintore","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0047","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1212\/WNL.0000000000003078","article-title":"The 11-year long-term follow-up study from the randomized BENEFIT CIS trial","volume":"87","author":"Kappos","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0048","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1093\/brain\/awt281","article-title":"Sex as a determinant of relapse incidence and progressive course of multiple sclerosis","volume":"136","author":"Kalincik","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0049","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/brain\/114.2.1045","article-title":"The natural history of multiple sclerosis: a geographically based study: 3. Multivariate analysis of predictive factors and models of outcome","volume":"114","author":"Weinshenker","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0050","first-page":"210","article-title":"Deep grey matter volume loss drives disability worsening in multiple sclerosis","volume":"83","author":"Eshaghi","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0051","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJM200011163432001","article-title":"Relapses and progression of disability in multiple sclerosis","volume":"343","author":"Confavreux","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0052","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(11)70274-5","article-title":"Clinically isolated syndromes","volume":"11","author":"Miller","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0053","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/ana.10240","article-title":"Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis","volume":"52","author":"Dalton","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0054","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00115-013-3845-1","article-title":"Klinisch isoliertes Syndrom","volume":"84","author":"Platten","year":"2013","journal-title":"Nervenarzt"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0055","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1177\/1352458508096878","article-title":"Differential diagnosis of suspected multiple sclerosis: a consensus approach","volume":"14","author":"Miller","year":"2008","journal-title":"Mult Scler J"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0056","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4103\/0972-2327.150622","article-title":"Lhermitte\u2032s sign: the current status","volume":"18","author":"Khare","year":"2015","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0057","doi-asserted-by":"crossref","first-page":"380","DOI":"10.7861\/clinmed.2020-0292","article-title":"Clinical presentation and diagnosis of multiple sclerosis","volume":"20","author":"Ford","year":"2020","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0058","doi-asserted-by":"crossref","first-page":"162","DOI":"10.5811\/cpcem.2022.2.55317","article-title":"Newly diagnosed multiple sclerosis presenting as Brown-S\u00e9quard syndrome: a case report","volume":"6","author":"Hoebee","year":"2022","journal-title":"Clin Pract Cases Emerg Med"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0059","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00007632-199501150-00023","article-title":"Brown-S\u00e8quard syndrome associated with Horner\u02bcs syndrome in cervical epidural hematoma","volume":"20","author":"Shen","year":"1995","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0060","first-page":"1236","article-title":"Optic neuritis","volume":"25","author":"Bennett","year":"2019","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0061","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/archopht.1991.01080120057025","article-title":"The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group","volume":"109","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0062","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00106-003-0942-7","article-title":"[Dissociated nystagmus in side gaze. Major symptoms in the diagnosis of an internuclear ophthalmoplegia]","volume":"52","author":"Neugebauer","year":"2004","journal-title":"HNO"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0063","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archneur.1985.04060080029011","article-title":"The clinical spectrum of internuclear ophthalmoplegia in multiple sclerosis","volume":"42","author":"Muri","year":"1985","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0064","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1001\/archneur.1986.00520050018014","article-title":"Clinical and oculographic examinations of saccadic eye movements in the diagnosis of multiple sclerosis","volume":"43","author":"Meienberg","year":"1986","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0065","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2147\/TCRM.S2515","article-title":"Multiple sclerosis presented as clinically isolated syndrome: the need for early diagnosis and treatment","volume":"4","author":"Pelidou","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0066","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1212\/01.wnl.0000435551.90824.d0","article-title":"Gray matter damage predicts the accumulation of disability 13 years later in MS","volume":"81","author":"Filippi","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0067","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ana.21375","article-title":"Predicting progression in primary progressive multiple sclerosis: a 10-year multicenter study","volume":"63","author":"Khaleeli","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0068","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.neubiorev.2013.03.006","article-title":"Localized grey matter atrophy in multiple sclerosis: a meta-analysis of voxel-based morphometry studies and associations with functional disability","volume":"37","author":"Lansley","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0069","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ana.21436","article-title":"Gray matter atrophy in multiple sclerosis: a longitudinal study","volume":"64","author":"Fisher","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0070","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1177\/1352458514528762","article-title":"Risk of relapse phenotype recurrence in multiple sclerosis","volume":"20","author":"Kalincik","year":"2014","journal-title":"Mult Scler J"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0071","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.13819","article-title":"Multiple sclerosis \u2013 a review","volume":"26","author":"Dobson","year":"2019","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0072","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S1474-4422(08)70259-X","article-title":"Cognitive impairment in multiple sclerosis","volume":"7","author":"Chiaravalloti","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0073","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.pop.2015.01.007","article-title":"Multiple sclerosis","volume":"42","author":"Files","year":"2015","journal-title":"Prim Care Clin Off Pract"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0074","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta6100","article-title":"A review of the natural history and epidemiology of multiple sclerosis: implications for resource allocation and health economic models","volume":"6","author":"Richards","year":"2002","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0075","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/1352458506071210","article-title":"Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis","volume":"13","author":"Nortvedt","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0076","doi-asserted-by":"crossref","first-page":"220","DOI":"10.12968\/bjon.2010.19.4.46783","article-title":"Bowel problems and coping strategies in people with multiple sclerosis","volume":"19","author":"Norton","year":"2010","journal-title":"Br J Nurs"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0077","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11916-019-0800-2","article-title":"Advances in the understanding and management of chronic pain in multiple sclerosis: a comprehensive review","volume":"23","author":"Urits","year":"2019","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0078","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12894-020-0581-2","article-title":"Sexual dysfunction in women with multiple sclerosis: prevalence and impact on quality of life","volume":"20","author":"Nazari","year":"2020","journal-title":"BMC Urol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0079","first-page":"418","article-title":"Sexual dysfunction in multiple sclerosis: a case-control study. I. Frequency and comparison of groups","volume":"5","author":"Zorzon","year":"1999","journal-title":"Mult Scler J"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0080","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/B978-0-444-63247-0.00020-1","article-title":"Sexual dysfunction in patients with multiple sclerosis","volume":"130","author":"Lew-Starowicz","year":"2015","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0081","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.jsxm.2018.09.016","article-title":"Association between multiple sclerosis and risk of female sexual dysfunction: a systematic review and meta-analysis","volume":"15","author":"Zhao","year":"2018","journal-title":"J Sex Med"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0082","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.msard.2012.08.004","article-title":"Substantial burden of dizziness in multiple sclerosis","volume":"2","author":"Marrie","year":"2013","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0083","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jns.2016.11.067","article-title":"Prevalence of depression and anxiety in multiple sclerosis: a systematic review and meta-analysis","volume":"372","author":"Boeschoten","year":"2017","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0084","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1177\/1352458508092807","article-title":"Prevalence of sleep problems in individuals with multiple sclerosis","volume":"14","author":"Bamer","year":"2008","journal-title":"Mult Scler J"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0085","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1352458517751049","article-title":"ECTRIMS\/EAN Guideline on the pharmacological treatment of people with multiple sclerosis","volume":"24","author":"Montalban","year":"2018","journal-title":"Mult Scler"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0086","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1212\/WNL.0000000000004740","article-title":"Epilepsy in multiple sclerosis: a nationwide population-based register study","volume":"89","author":"Burman","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0087","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102462","article-title":"Urinary tract infection in patients with multiple sclerosis: an overview","volume":"46","author":"Medeiros Junior","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0088","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1111\/ene.15077","article-title":"Nitrous oxide-induced myeloneuropathy","volume":"28","author":"Swart","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0089","doi-asserted-by":"crossref","first-page":"290","DOI":"10.7224\/1537-2073.2016-069","article-title":"Triaging patients with multiple sclerosis in the emergency department","volume":"19","author":"Abboud","year":"2017","journal-title":"Int J MS Care"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0090","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0091","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","article-title":"New diagnostic criteria for multiple sclerosis: guidelines for research protocols","volume":"13","author":"Poser","year":"1983","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0092","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/jpm12010006","article-title":"Recommendations for the diagnosis and treatment of multiple sclerosis relapses","volume":"12","author":"Ramo-Tello","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0093","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJM200102013440501","article-title":"Vaccines in Multiple Sclerosis Study Group. Vaccinations and the risk of relapse in multiple sclerosis","volume":"344","author":"Confavreux","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0094","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/BF00867354","article-title":"Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study","volume":"240","author":"Andersen","year":"1993","journal-title":"J Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0095","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1212\/WNL.0b013e3182616ff9","article-title":"A randomized trial of stress management for the prevention of new brain lesions in MS","volume":"79","author":"Mohr","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0096","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/jamaneurol.2017.1668","article-title":"Recrudescence of deficits after stroke: clinical and imaging phenotype, triggers, and risk factors","volume":"74","author":"Topcuoglu","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0097","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrneurol.2013.98","article-title":"Uhthoff's phenomena in MS\u2014clinical features and pathophysiology","volume":"9","author":"Frohman","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0098","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0099","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.msard.2016.07.014","article-title":"Rethinking the importance of paroxysmal and unusual symptoms as first clinical manifestation of multiple sclerosis: they do matter","volume":"9","author":"Ehling","year":"2016","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0100","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/archneur.1984.04050180069020","article-title":"Paroxysmal dystonia as the initial manifestation of multiple sclerosis","volume":"41","author":"Berger","year":"1984","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0101","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1136\/jnnp.43.4.296","article-title":"Paroxysmal symptoms as the first manifestations of multiple sclerosis","volume":"43","author":"Twomey","year":"1980","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0102","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1191\/1352458502ms812oa","article-title":"Epileptic seizures, cranial neuralgias and paroxysmal symptoms in remitting and progressive multiple sclerosis","volume":"8","author":"Eriksson","year":"2002","journal-title":"Mult Scler J"},{"issue":"suppl 1","key":"10.1016\/j.jemermed.2023.12.003_bib0103","first-page":"S1","article-title":"Multiple sclerosis: diagnosis and differential diagnosis","volume":"55","author":"\u00d6merhoca","year":"2018","journal-title":"Noro Psikiyatr Ars"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0104","doi-asserted-by":"crossref","unstructured":"Gaillard F, Ranchod A, Yap J, et al. Multiple sclerosis. Available at: https:\/\/doi.org\/10.53347\/rID-1700. Accessed July 12, 2023.","DOI":"10.53347\/rID-1700"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0105","doi-asserted-by":"crossref","unstructured":"Gaillard F. Multiple sclerosis of the spine. Available at: https:\/\/doi.org\/10.53347\/rID-2635. Accessed July 12, 2023.","DOI":"10.53347\/rID-2635"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0106","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1212\/01.WNL.0000046587.83503.1E","article-title":"MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals","volume":"60","author":"Cotton","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0107","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1474-4422(21)00095-8","article-title":"2021 MAGNIMS\u2013CMSC\u2013NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis","volume":"20","author":"Wattjes","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0108","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000166602","article-title":"Monthly ambient sunlight, infections and relapse rates in multiple sclerosis","volume":"31","author":"Tremlett","year":"2008","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0109","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrneurol.2012.43","article-title":"Sex-related factors in multiple sclerosis susceptibility and progression","volume":"8","author":"Voskuhl","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0110","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/jnnp-2018-319301","article-title":"Food allergies are associated with increased disease activity in multiple sclerosis","volume":"90","author":"Fakih","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0111","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000470904","article-title":"Sleep disorder as a triggering factor for relapse in multiple sclerosis","volume":"77","author":"Sahraian","year":"2017","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0112","doi-asserted-by":"crossref","DOI":"10.1177\/2055102915612271","article-title":"Stress and multiple sclerosis: a systematic review considering potential moderating and mediating factors and methods of assessing stress","volume":"2","author":"Briones-Buixassa","year":"2015","journal-title":"Health Psychol Open"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0113","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/23328940.2018.1475831","article-title":"Temperature sensitivity in multiple sclerosis: an overview of its impact on sensory and cognitive symptoms","volume":"5","author":"Christogianni","year":"2018","journal-title":"Temperature (Austin)"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0114","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.3390\/jcm9103100","article-title":"Paroxysmal symptoms in multiple sclerosis\u2014a review of the literature","volume":"9","author":"Freiha","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0115","series-title":"Multiple sclerosis in adults: management","year":"2022"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0116","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fneur.2013.00021","article-title":"Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormone","volume":"4","author":"Ross","year":"2013","journal-title":"Front Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0117","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/WNF.0b013e31820a17f3","article-title":"Intravenous immunoglobulins are a therapeutic option in the treatment of multiple sclerosis relapse","volume":"34","author":"Elovaara","year":"2011","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0118","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/cns.12985","article-title":"Intravenous immunoglobulin treatment in multiple sclerosis: a prospective, rater-blinded analysis of relapse rates during pregnancy and the postnatal period","volume":"25","author":"Winkelmann","year":"2019","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0119","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00415-004-0495-z","article-title":"Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis","volume":"251","author":"Achiron","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0120","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/1756285608100416","article-title":"Immunomodulation and postpartum relapses in patients with multiple sclerosis","volume":"2","author":"Hellwig","year":"2009","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0121","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1177\/1352458506075654","article-title":"A dose comparison study of IVIG in postpartum relapsing-remitting multiple sclerosis","volume":"13","author":"Haas","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0122","article-title":"Plasma exchange for multiple sclerosis","volume":"2018","author":"Casetta","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0123","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.eclinm.2019.10.017","article-title":"Safety and efficacy of immunoadsorption versus plasma exchange in steroid-refractory relapse of multiple sclerosis and clinically isolated syndrome: a randomised, parallel-group, controlled trial","volume":"16","author":"Dorst","year":"2019","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0124","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00115-006-2053-7","article-title":"Pregnancy and immunomodulatory therapy in multiple sclerosis patients","volume":"77","author":"Hoffmann","year":"2006","journal-title":"Nervenarzt"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0125","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1191\/1352458504ms1083oa","article-title":"Multiple sclerosis gender issues: clinical practices of women neurologists","volume":"10","author":"Coyle","year":"2004","journal-title":"Mult Scler"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0126","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1212\/WNL.39.9.1143","article-title":"Double-blind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis","volume":"39","author":"Weiner","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0127","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0140-6736(15)61137-0","article-title":"Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial","volume":"386","author":"Le Page","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0128","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.msard.2017.12.001","article-title":"Plasma exchange in severe acute relapses of multiple sclerosis \u2013 results from a Portuguese cohort","volume":"19","author":"Correia","year":"2018","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0129","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1212\/WNL.0b013e318207b1f6","article-title":"Rae-Grant A. Evidence-based guideline update: plasmapheresis in neurologic disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology","volume":"76","author":"Cortese","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s13311-012-0160-7","article-title":"Treatment of acute relapses in multiple sclerosis","volume":"10","author":"Berkovich","year":"2013","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0131","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1472-6963-3-17","article-title":"Cost of managing an episode of relapse in multiple sclerosis in the United States","volume":"3","author":"O'Brien","year":"2003","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0132","doi-asserted-by":"crossref","first-page":"e899","DOI":"10.1212\/WNL.0000000000201645","article-title":"Direct health care costs associated with multiple sclerosis: a population-based cohort study in British Columbia, Canada, 2001\u20132020","volume":"100","author":"Khakban","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0133","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1212\/WNL.0000000000003152","article-title":"The contemporary spectrum of multiple sclerosis misdiagnosis: a multicenter study","volume":"87","author":"Solomon","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0134","article-title":"Improving outcomes in multiple sclerosis through early diagnosis and effective management: commentary","volume":"14","author":"Waubant","year":"2012","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0135","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1212\/01.wnl.0000237641.33768.8d","article-title":"Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes","volume":"67","author":"Kappos","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0136","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM200009283431301","article-title":"Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group","volume":"343","author":"Jacobs","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0137","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2010.02.008","article-title":"Poor recovery after the first two attacks of multiple sclerosis is associated with poor outcome five years later","volume":"292","author":"Scott","year":"2010","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0138","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1212\/01.wnl.0000342458.39625.91","article-title":"Demyelinating events in early multiple sclerosis have inherent severity and recovery","volume":"72","author":"Mowry","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0139","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/brain\/awq118","article-title":"The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability","volume":"133","author":"Scalfari","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.msard.2019.04.017","article-title":"Worsening of disability caused by relapses in multiple sclerosis: a different approach","volume":"32","author":"Koch-Henriksen","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0141","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/ane.13149","article-title":"Multiple sclerosis relapses contribute to long-term disability","volume":"140","author":"Scott","year":"2019","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jemermed.2023.12.003_bib0142","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/ana.25463","article-title":"Silent progression in disease activity\u2013free relapsing multiple sclerosis","volume":"85","author":"Cree","year":"2019","journal-title":"Ann Neurol"}],"container-title":["The Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467923005917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467923005917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T08:00:37Z","timestamp":1712217637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0736467923005917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":142,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0736467923005917"],"URL":"https:\/\/doi.org\/10.1016\/j.jemermed.2023.12.003","relation":{},"ISSN":["0736-4679"],"issn-type":[{"value":"0736-4679","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple Sclerosis: An Emergency Medicine-Focused Narrative Review","name":"articletitle","label":"Article Title"},{"value":"The Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jemermed.2023.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}